U.S. Machinery Stock News

NYSE:CFG
NYSE:CFGBanks

Large Cap Dividend Stocks For Income Investors As Rate Cut Hopes Build

With Asian stocks climbing and the odds of a US rate hike in September easing, income investors are watching a rare mix of relief and uncertainty. Lower rate expectations can change how dividend stocks trade, especially with CPI data and rising oil prices still in play. This article walks through three large cap dividend stocks from our screener that appear well placed, highlighting where the current backdrop may help or hinder your income plan. The three stocks below are a useful starting...
NYSE:ESAB
NYSE:ESABMachinery

Will Record Sales, Eddyfi Deal and Raised 2026 Outlook Change ESAB's (ESAB) Margin Narrative?

ESAB Corporation recently reported its second-quarter 2026 results, with sales rising to US$807.63 million from US$715.59 million a year earlier, while net income fell to US$32.35 million from US$66.88 million. Alongside record sales and an earnings miss, ESAB closed the Eddyfi acquisition ahead of schedule and raised its 2026 outlook, tying short-term margin pressure to what management describes as stronger long-term demand and expanded technology capabilities. We’ll now examine how ESAB’s...
NYSE:TTI
NYSE:TTIEnergy Services

TETRA Technologies (TTI) Could Be 32% Below Fair Value After Arkansas Bromine Approval

Why the latest earnings matter for TETRA Technologies stock TETRA Technologies (TTI) has become a focus for investors after its second quarter earnings on 3 August 2026, which paired revenue and EBITDA growth with a final go ahead for the Arkansas bromine project. See our latest analysis for TETRA Technologies. Over the past year TETRA Technologies has delivered a very strong 1 year total shareholder return of 117.09%. However, the share price is down 16.40% over 3 months and 9.95% over 30...
NYSE:KMI
NYSE:KMIOil and Gas

Is Kinder Morgan (KMI) Undervalued After Its New Bond Offerings?

Why Kinder Morgan stock is back in focus after new bond offerings Kinder Morgan (KMI) recently completed several fixed income offerings, including senior unsecured fixed rate notes with attached guarantees. These new bonds give investors fresh information about the company’s funding mix and balance sheet decisions. The transactions include US$595.782 million of 6.150% notes due August 1, 2056 and US$1.149138 billion of 5.550% notes due August 1, 2036. Both sets of notes are senior, unsecured,...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Selective Insurance Group (SIGI) Leans On Efficiency Story, Does It Look Fairly Valued?

Why Selective Insurance Group Is On Investor Radar Today Selective Insurance Group (SIGI) is drawing investor attention after recent trading put its shares around $96.23, with performance figures available for the past week, month, past 3 months, year to date, and 1 year. See our latest analysis for Selective Insurance Group. Recent trading puts Selective Insurance Group’s share price at $96.23, with a 12.04% 90 day share price return and a 26.54% 1 year total shareholder return. This may...
NYSE:MTX
NYSE:MTXChemicals

How Investors Are Reacting To Minerals Technologies (MTX) Margin-Recovery Guidance After a Surprise Quarterly Loss

Minerals Technologies recently reported second-quarter 2026 results, with sales rising to US$548.4 million but swinging to a net loss of US$183.6 million, and followed this with full-year 2026 guidance calling for around US$75 million in quarterly operating income and earnings per share between US$1.55 and US$1.60. Management acknowledged near-term pressure but emphasized a planned recovery in operating margins above prior-year levels in the fourth quarter, underpinned by seasonality and...
NasdaqGS:MSEX
NasdaqGS:MSEXWater Utilities

Middlesex Water (MSEX), Why Is Its Latest Update Drawing Attention?

Middlesex Water (MSEX) is in focus after reporting second quarter 2026 results, with sales of US$56.36 million and net income of US$14.77 million, both above the figures reported a year earlier. See our latest analysis for Middlesex Water. Middlesex Water’s recent earnings release has arrived alongside a firm share price recovery, with a 5.84% 1 month share price return, a 12.11% 3 month share price return and a 15.81% year to date share price return. The 1 year total shareholder return of...
NYSE:CNMD
NYSE:CNMDMedical Equipment

Is CONMED’s (CNMD) Earnings Beat And Higher Sales Outlook Reframing Its Core Investment Story?

In July 2026, CONMED Corporation reported past second-quarter 2026 results showing sales of US$343.49 million and net income of US$23.07 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. For the first half of 2026, CONMED grew net income to US$36.90 million despite slightly lower sales, and marginally raised its full-year GAAP net sales guidance range to US$1.36 billion–US$1.37 billion. Now we’ll examine how this earnings...
NYSE:NNN
NYSE:NNNRetail REITs

Raised AFFO Guidance And 37th Dividend Hike Could Be A Game Changer For NNN REIT (NNN)

NNN REIT, Inc. recently reported its second-quarter 2026 results, showing revenue of US$244.27 million and net income of US$97.92 million, while also filing and completing follow-on common equity offerings and a broad shelf registration for multiple securities. Alongside this, the company raised its 2026 AFFO-per-share guidance, increased its quarterly dividend for the 37th consecutive year, and continued investing heavily in new properties while maintaining occupancy above 99%. With NNN...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Why Sarepta Therapeutics (SRPT) Is Up 12.9% After Cutting 2026 Guidance And Naming A New CEO

Sarepta Therapeutics recently narrowed its 2026 total net product revenue guidance to US$1.20 billion–US$1.30 billion and reported second-quarter 2026 revenue of US$401.25 million, down from US$611.09 million a year earlier, with a quarterly net loss of US$4.89 million. Alongside weaker quarterly results, the company is undergoing leadership change with Michael Severino, M.D., a veteran of AbbVie, Amgen, and Merck, stepping in as Chief Executive Officer and joining the Board, while Sarepta...
NYSE:MTH
NYSE:MTHConsumer Durables

Meritage Homes (MTH) Could Be 7% Undervalued After Softer Q2 And Weaker 2026 Outlook

Meritage Homes (MTH) shares reacted to a softer second quarter update, as the company reported lower revenue and earnings and guided 2026 home closings and revenue to about 5% below 2025 levels. See our latest analysis for Meritage Homes. Despite the softer Q2 update and 2026 guidance, Meritage Homes shares have kept positive momentum, with the recent 90-day share price return of 19.38% and a year-to-date share price return of 12.62%. The 5-year total shareholder return of 38.35% reflects a...
NYSE:RIG
NYSE:RIGEnergy Services

Should Transocean’s (RIG) Return to Profitability and Free Cash Flow Generation Require Action From Investors?

In the second quarter of 2026, Transocean Ltd. reported a net income of US$170 million versus a net loss of US$938 million a year earlier, with basic earnings per share from continuing operations improving to US$0.15. Over the first half of 2026, Transocean shifted from a US$1.02 billion loss to a US$241 million profit, underpinned by higher revenue, stronger margins, and meaningful free cash flow generation. Now we'll examine how this sharp swing back to profitability and strong free cash...
NYSE:BKH
NYSE:BKHIntegrated Utilities

What Black Hills (BKH)'s Strong Q2 Earnings and Steady Dividend Means For Shareholders

Black Hills Corporation recently reported its second-quarter 2026 results, with sales rising to US$452.8 million and net income increasing to US$38.2 million, while also confirming six-month net income of US$169.2 million on sales of US$1.23 billion. The combination of higher quarterly earnings per share and an affirmed quarterly dividend of US$0.703 per share underscores management’s focus on sustaining shareholder payouts alongside improving profitability. We’ll now examine how Black...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Stock Price Slips Despite Profit Surge

Berkshire Hathaway stock slipped about 0.8% today, a modest pullback for a company often treated as the market’s ultimate safety net. The move came as investors digested a powerful earnings headline. Quarterly net income excluding extra items landed at about US$25.7b on revenue of roughly US$101.8b, leaving the past 12 months with a trailing net margin a little above 22%. For a business built on insurance float, rail, utilities and a large equity portfolio, that profitability is the real...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

Did Brighthouse’s (BHF) Q2 Profit Surge and H1 Turnaround Just Recast Its Investment Narrative?

In the past quarter, Brighthouse Financial, Inc. reported second-quarter 2026 revenue of US$1,622 million and net income of US$981 million, with diluted earnings per share from continuing operations of US$16.53, marking a very large year-over-year increase in profitability. Over the first half of 2026, the company moved from a net loss a year earlier to net income of US$215 million, indicating a sharp turnaround in its earnings profile despite slightly lower year-to-date revenue. Next, we’ll...
NYSE:PJT
NYSE:PJTCapital Markets

PJT Partners (PJT) Could Be 19% Undervalued As Earnings And Buybacks Draw Focus

PJT Partners (PJT) has drawn fresh attention after reporting higher second quarter and year to date earnings, along with continued share repurchases and a declared quarterly dividend of $0.25 per Class A share. See our latest analysis for PJT Partners. At a share price of $171.34, PJT Partners has seen a 30 day share price return of 9.19% and a 90 day share price return of 11.74%, while the 1 year total shareholder return has declined 2.35%. Recent interest appears linked to stronger...
NYSE:SPXC
NYSE:SPXCMachinery

Can SPX Technologies (SPXC) Justify Its Valuation On Strong Earnings And Raised Guidance?

Why SPX Technologies Earnings Matter For Investors Now SPX Technologies (SPXC) is in focus after second quarter 2026 results showed higher sales of US$679 million and net income of US$78.4 million compared with the prior year, along with increased full year revenue guidance. See our latest analysis for SPX Technologies. SPX Technologies shares trade at US$215.68 after a 6.1% year to date share price return and a 7% one year total shareholder return. The three year total shareholder return of...
NYSE:SR
NYSE:SRGas Utilities

What Spire (SR)'s Divestitures, Earnings Beat and Dividend Hike Mean For Shareholders

Spire Inc. has reported its third-quarter and nine-month results to June 30, 2026, showing higher sales and net income, while also completing the divestitures of Spire Marketing and Spire Storage and continuing its long history of regular dividends, including a US$0.825 per share payout declared for October 2, 2026. Beyond the headline growth in earnings, the combination of divestitures, reaffirmed multi-year EPS guidance, and a 23-year streak of annual dividend increases highlights Spire's...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

Is Laureate Education (LAUR) Fairly Valued On Raised Guidance And A Bigger Buyback?

Laureate Education (LAUR) had a busy July 30, 2026, reporting raised full year revenue guidance, solid second quarter results, and a larger share buyback authorization that adds a fresh angle for investors. See our latest analysis for Laureate Education. Over the past year, Laureate Education has combined a 15.1% year to date share price return with a 1 year total shareholder return of 49.65%. The recent 30 day share price pullback of 5.24% comes after a 16.96% 90 day gain, which suggests...
NYSE:KWR
NYSE:KWRChemicals

Quaker Chemical (KWR) Is Up 5.9% After Strong Q2, Dividend Hike And M&A Push - Has The Bull Case Changed?

In late July 2026, Quaker Chemical reported stronger second-quarter results with higher sales and a return to profitability, raised its quarterly dividend to US$0.53 per share, refreshed its capital structure, filed shelf registrations for common shares, and confirmed it is actively pursuing acquisitions to support long-term growth. The combination of improved earnings, a higher cash dividend, a new share repurchase authorization, and management’s emphasis on disciplined M&A highlights a...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Founder Led Stocks With Buybacks Profits And Room For Repricing

With global food costs climbing again, as seen in the latest rise in the FAO Food Price Index, investors are watching how pricing power and leadership quality interact. Founder led companies often live or die by the decisions of a single, deeply invested leader. That makes this a compelling moment to focus on founders who are building legacies. This article highlights three standout stocks from the Founder Led Companies screener. The stocks covered below are just a small sample, and the full...
NYSE:CCS
NYSE:CCSConsumer Durables

Does Argus’s Downgrade of Century Communities (CCS) Reveal Shifting Conviction in Its Valuation Story?

Earlier this week, Argus cut its rating on Century Communities Inc. (CCS), a U.S. homebuilder focused on single-family attached and detached homes, to SELL without citing new operational developments. The absence of fresh business updates around the downgrade highlights how changes in analyst opinions alone can meaningfully sway market expectations for Century Communities. We’ll now examine how Argus’s SELL downgrade may reshape Century Communities’ investment narrative, particularly around...
NasdaqCM:FRNM
NasdaqCM:FRNMBiotechs

Freenome (FRNM) Following FDA Approval Why Its 36.8x P S Still Looks Pricey

Freenome (FRNM) stock is in focus after the company and Abbott received U.S. Food and Drug Administration approval for SimpleScreen CRC, a blood based colorectal cancer screening test for average risk adults. See our latest analysis for Freenome. The FDA approval and upcoming U.S. launch of SimpleScreen CRC comes as Freenome trades at US$11.15, with a 30 day share price return of 3.24% and a year to date share price decline of 14.23%. The 1 year total shareholder return is 5.49%, suggesting...